Takeda Pharmaceutical
290 hedge funds and large institutions have $1.51B invested in Takeda Pharmaceutical in 2021 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 88 increasing their positions, 91 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
290
Holders Change
-12
Holders Change %
-3.97%
% of All Funds
5.09%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
29
Increased
88
Reduced
91
Closed
38
Calls
$66.6M
Puts
$23.1M
Net Calls
+$43.6M
Net Calls Change
+$13.4M
Top Buyers
| 1 |
Citigroup
New York
|
+$34.7M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$31.4M |
| 3 |
Goldman Sachs
New York
|
+$11.7M |
| 4 |
Barclays
London,
United Kingdom
|
+$7.11M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$5.51M |
Top Sellers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$32.6M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$32.3M |
| 3 |
GCM
Glenview Capital Management
New York
|
-$16.6M |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
-$9.23M |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$8.6M |
